[THE IMPORTANCE OF THE DISTRIBUTION OF THE DOSAGE FIELD IN TELEGAMMATHERAPY OF CANCER OF THE UTERINE CERVIX].
D005260:Female; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011867:Radioisotope Teletherapy; D002583:Uterine Cervical Neoplasms
CERVIX NEOPLASMS; NEOPLASM RADIOTHERAPY; RADIOISOTOPE TELETHERAPY
DIE BEDEUTUNG DER VERTEILUNG DES DOSISFELDES BEI DER TELEGAMMATHERAPIE DES KOLLUMKARZINOMS.